Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/5/14 → 12/31/20 |
Funding
- St. Jude Children's Research Hospital (PBTC 042 (PD-0332991))
- Pfizer Inc (PBTC 042 (PD-0332991))
PBTC-042 - Phase I study of CDK 4-6 inhibitor PD-0332991 in children with recurrent, progressive or refractory central nervous system tumors
- Goldman, Stewart (PD/PI)
Project: Research project